ARTICLE
8 January 2018

Ontario Bill 160 Requiring Disclosure Of Financial Relationships Between Pharmaceutical Companies And Health Care Professionals Receives Royal Assent

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
The Health Sector Payment Transparency Act, 2017 will come into force on a day to be named by proclamation of the Lieutenant Governor.
Canada Food, Drugs, Healthcare, Life Sciences

On December 12, 2017, Ontario Bill 160, the Strengthening Quality and Accountability for Patients Act, 2017, received Royal Assent. As previously reported, Bill 160 enacts or amends ten statutes (see News Release for highlights), including enacting the Health Sector Payment Transparency Act, 2017 (Transparency Act). When in force, the Transparency Act will require payors, including manufacturers of pharmaceutical or medical devices, to report financial relationships with health care professionals and organizations, as well as other prescribed recipients. The reported information will be made publicly available. Regulations, not yet released, will prescribe many of the details, including the definition of a 'recipient', the manner and frequency of reporting, and which transfers of value will be exempted from reporting. The Health Sector Payment Transparency Act, 2017 will come into force on a day to be named by proclamation of the Lieutenant Governor.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More